Aphria to commence trading on the NYSE on November 2

Aphria to commence trading on the NYSE on November 2
Aphria to commence trading on the NYSE on November 2

  • Aphria's shares will trade on the NYSE under ticker symbol "APHA"
  • Ticker symbol on the Toronto Stock Exchange (TSX) will also change from "APH" to "APHA"

Aphria Inc. (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018.

Aphria's shares will trade on the NYSE under ticker symbol "APHA". The Company's ticker symbol on the Toronto Stock Exchange (TSX) will also change from "APH" to "APHA", effective November 2, 2018. Existing shares of Aphria, which previously traded on the OTCQB under the ticker symbol "APHQF" will now trade on the NYSE.

"Listing on the NYSE provides Aphria with access to the largest equity market in the world, with increased exposure to a vast array of US institutional and retail investors. This strategic move aligns directly with our growth ambitions as we enter an elite peer group of respected, high-profile corporate brands listed on the NYSE," said Vic Neufeld, Aphria CEO.

Mr. Neufeld added: "We are excited to usher in a new era with the recent legalization of adult-use cannabis in Canadaand as we aim to further expand our footing in exciting markets such as Latin America, the Caribbean and Europe. Aphria is well-positioned to capitalize on this fast-growing industry."

Upon commencement of trading on the NYSE, Aphria intends to voluntarily delist its shares from the OTCQB. While shareholders are not required to take any action, the Company recommends that holders who bought shares on the OTCQB monitor their institution/brokerage account to ensure their holdings are correctly reflected under the new ticker symbol.

We Have A Good Thing Growing 

About Aphria

Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company's portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders' multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.

For more information, visit: aphria.ca

SOURCE

CBD Beverage Stocks Are Pouring Investor Profits

Click Here For Free Report